Tag: ASIT Biotech

March 20, 2017 Off

ASIT biotech welcomes new Chairman of the Board

By Dino Mustafić

ASIT biotech, a Belgian clinical-stage biopharmaceutical company focused on the research, development and future commercialization of immunotherapy products for the treatment of allergies, has appointed Gerd Zettlmeissl as its new Chairman of the Board, Béatrice De Vos having stood down to focus on new projects.